Wnt signaling and telomerase activation of hepatoblastoma: Correlation with chemosensitivity and surgical resectability

Journal of Pediatric Surgery

Volumn 46, Issue 12, 2011, Pages 2221-2227

  Ueda, Yuka ^a   Hiyama, Eiso ^a,b,c   Kamimatsuse, Arata ^a,b   Kamei, Naomi ^a,b   Ogura, Kaoru ^a,b   Sueda, Taijiro ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Chemosensitivity; Hepatoblastoma; Outcome; Telomerase; TERT; Wnt catenin

Indexed keywords

ANTINEOPLASTIC AGENT; BETA CATENIN; CELL PROTEIN; CTNNB1 PROTEIN; MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; WNT PROTEIN;

ADOLESCENT; CANCER CHEMOTHERAPY; CANCER SURGERY; CHEMOSENSITIVITY; CLINICAL EFFECTIVENESS; CONFERENCE PAPER; DISTANT METASTASIS; ENZYME ACTIVATION; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HEPATOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATECTOMY; HUMANS; INFANT; LIVER NEOPLASMS; MALE; MUTATION, MISSENSE; NEOPLASM PROTEINS; SEQUENCE DELETION; TELOMERASE; TREATMENT OUTCOME; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 83455188012     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.09.003     Document Type: Conference Paper

References (37)

1. A.G. Weinberg, and M.J. Finegold Primary hepatic tumors of childhood Hum Pathol 14 1983 512 537
2. R.M. Conran, C.L. Hitchcock, and M.A. Waclawiw Hepatoblastoma: the prognostic significance of histologic type Pediatr Pathol 12 1992 167 183
3. K. Yun, Y. Jinno, and T. Sohda Promoter-specific insulin-like growth factor 2 gene imprinting in human fetal liver and hepatoblastoma J Pathol 185 1998 91 98
4. R. Fukuzawa, A. Umezawa, and K. Ochi High frequency of inactivation of the imprinted H19 gene in "sporadic" hepatoblastoma Int J Cancer 82 1999 490 497
5. F.P. Li, W.A. Thurber, and J. Seddon Hepatoblastoma in families with polyposis coli JAMA 257 1987 2475 2477
6. K.W. Kinzler, and B. Vogelstein Lessons from hereditary colorectal cancer Cell 87 1996 159 170
7. S. Ichii, A. Horii, and S. Nakatsuru Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP) Hum Mol Genet 1 1992 387 390
8. A. Koch, D. Denkhaus, and S. Albrecht Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the beta-catenin gene Cancer Res 59 1999 269 273
9. C. Armengol, S. Cairo, and M. Fabre Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model Int J Biochem Cell Biol 43 2011 265 270
10. J. Miao, T. Kusafuka, and Y. Udatsu Sequence variants of the Axin gene in hepatoblastoma Hepatol Res 25 2003 174 179
11. O. Huber, R. Korn, and J. McLaughlin Nuclear localization of beta-catenin by interaction with transcription factor LEF-1 Mech Dev 59 1996 3 10
12. O. Tetsu, and F. McCormick Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells Nature 398 1999 422 426
13. E. Hiyama, and K. Hiyama Telomere and telomerase in stem cells Br J Cancer 96 2007 1020 1024
14. J.W. Shay, Y. Zou, and E. Hiyama Telomerase and cancer Hum Mol Genet 10 2001 677 685
15. E. Hiyama, K. Hiyama, and T. Yokoyama Correlating telomerase activity levels with human neuroblastoma outcomes Nat Med 1 1995 249 255
16. E. Hiyama, H. Yamaoka, and T. Matsunaga High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma Br J Cancer 91 2004 972 979
17. J.I. Park, A.S. Venteicher, and J.Y. Hong Telomerase modulates Wnt signalling by association with target gene chromatin Nature 460 2009 66 72
18. T. Shalaby, E. Hiyama, and M.A. Grotzer Telomere maintenance as therapeutic target in embryonal tumours Anticancer Agents Med Chem 10 2010 196 212
19. F. Sasaki, T. Matsunaga, and M. Iwafuchi Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: a report from the Japanese Study Group for Pediatric Liver Tumor J Pediatr Surg 37 2002 851 856
20. Y. Hata The clinical features and prognosis of hepatoblastoma: follow-up studies done on pediatric tumors enrolled in the Japanese Pediatric Tumor Registry between 1971 and 1980. Part I. Committee of Malignant Tumors, Japanese Society of Pediatric Surgeons Jpn J Surg 20 1990 498 502
21. J. Brown, G. Perilongo, and E. Shafford Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1 Eur J Cancer 36 2000 1418 1425
22. J.E. Haas, K.A. Muczynski, and M. Krailo Histopathology and prognosis in childhood hepatoblastoma and hepatocarcinoma Cancer 64 1989 1082 1095
23. A. Sambrook, E.F. Fritish, and T. Maniatis Molecular cloning A laboratory manual 2nd ed 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
24. P. Chromczynski, and N. Sacchi Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 162 1987 156 159
25. Y. Onitake, E. Hiyama, and N. Kamei Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres J Pediatr Surg 44 2009 2258 2266
26. C.H. Anna, R.C. Sills, and J.F. Foley Beta-catenin mutations and protein accumulation in all hepatoblastomas examined from B6C3F1 mice treated with anthraquinone or oxazepam Cancer Res 60 2000 2864 2868
27. Y. Udatsu, T. Kusafuka, and S. Kuroda High frequency of beta-catenin mutations in hepatoblastoma Pediatr Surg Int 17 2001 508 512
28. T. Hishiki, T. Matsunaga, and F. Sasaki Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT Pediatr Surg Int 27 2011 1 8
29. Y.M. Jeng, M.Z. Wu, and T.L. Mao Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma Cancer Lett 152 2000 45 51
30. H. Takayasu, H. Horie, and E. Hiyama Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma Clin Cancer Res 7 2001 901 908
31. E. Hiyama, and K. Hiyama Telomerase as tumor marker Cancer Lett 194 2003 221 233
32. E. Hiyama, and K. Hiyama Clinical utility of telomerase in cancer Oncogene 21 2002 643 649
33. J.W. Shay, and S. Bacchetti A survey of telomerase activity in human cancer Eur J Cancer 33 1997 787 791
34. J. Gupta, L.P. Han, and P. Wang Development of retinoblastoma in the absence of telomerase activity J Natl Cancer Inst 88 1996 1152 1157
35. F.M. Giardiello, G.J. Offerhaus, and A.J. Krush Risk of hepatoblastoma in familial adenomatous polyposis J Pediatr 119 1991 766 768
36. C.H. Anna, M. Iida, and R.C. Sills Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice Toxicol Appl Pharmacol 190 2003 135 145
37. E. Hiyama, K. Hiyama, and H. Yamaoka Expression profiling of favorable and unfavorable neuroblastomas Pediatr Surg Int 20 2004 33 38